Free Trial

NewGenIvf Group (NIVF) Competitors

NewGenIvf Group logo
$0.52 -0.03 (-5.84%)
As of 02:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NIVF vs. BGLC, MGRX, SSY, VSEE, DHAC, ACON, OTRK, BACK, ATIP, and BTTX

Should you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include BioNexus Gene Lab (BGLC), Mangoceuticals (MGRX), SunLink Health Systems (SSY), VSee Health (VSEE), Digital Health Acquisition (DHAC), Aclarion (ACON), Ontrak (OTRK), IMAC (BACK), ATI Physical Therapy (ATIP), and Better Therapeutics (BTTX). These companies are all part of the "healthcare" industry.

NewGenIvf Group vs. Its Competitors

BioNexus Gene Lab (NASDAQ:BGLC) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

NewGenIvf Group has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -22.85%. NewGenIvf Group's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.

Company Net Margins Return on Equity Return on Assets
BioNexus Gene Lab-22.85% -24.18% -20.14%
NewGenIvf Group N/A N/A N/A

BioNexus Gene Lab has a beta of 5.08, meaning that its share price is 408% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of -0.03, meaning that its share price is 103% less volatile than the S&P 500.

In the previous week, NewGenIvf Group had 1 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 2 mentions for NewGenIvf Group and 1 mentions for BioNexus Gene Lab. BioNexus Gene Lab's average media sentiment score of 1.87 beat NewGenIvf Group's score of 0.93 indicating that BioNexus Gene Lab is being referred to more favorably in the media.

Company Overall Sentiment
BioNexus Gene Lab Very Positive
NewGenIvf Group Positive

18.9% of BioNexus Gene Lab shares are owned by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are owned by institutional investors. 0.7% of BioNexus Gene Lab shares are owned by insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

NewGenIvf Group has lower revenue, but higher earnings than BioNexus Gene Lab.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioNexus Gene Lab$9.51M0.93-$1.60MN/AN/A
NewGenIvf Group$5.43M0.41-$520KN/AN/A

Summary

NewGenIvf Group beats BioNexus Gene Lab on 7 of the 11 factors compared between the two stocks.

Get NewGenIvf Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NIVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NIVF vs. The Competition

MetricNewGenIvf GroupMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$2.23M$7.20B$5.71B$9.51B
Dividend YieldN/A2.81%4.60%3.99%
P/E RatioN/A24.7928.0720.02
Price / Sales0.4138.94459.47103.02
Price / CashN/A28.2736.5558.97
Price / Book-0.029.698.615.88
Net Income-$520K$236.91M$3.24B$258.50M
7 Day Performance-9.15%2.58%3.83%2.03%
1 Month Performance-50.38%5.77%10.40%12.52%
1 Year Performance-99.74%16.95%34.13%19.07%

NewGenIvf Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NIVF
NewGenIvf Group
N/A$0.52
-5.8%
N/A-99.7%$2.23M$5.43M0.00N/ANegative News
Gap Up
BGLC
BioNexus Gene Lab
1.2027 of 5 stars
$5.04
+2.1%
N/A-4.1%$9.04M$9.51M0.0030Gap Down
MGRX
Mangoceuticals
1.0601 of 5 stars
$1.72
-0.3%
N/A-98.1%$8.87M$620K-0.373Gap Up
SSY
SunLink Health Systems
2.5911 of 5 stars
$1.21
-2.0%
N/A+55.2%$8.20M$31.09M8.321,376News Coverage
Dividend Announcement
Gap Up
VSEE
VSee Health
1.1594 of 5 stars
$1.38
+0.7%
$5.00
+262.3%
-56.1%$4.97MN/A0.00N/AGap Up
DHAC
Digital Health Acquisition
N/A$1.35
-3.6%
N/A-62.8%$4.87MN/A0.002,021Gap Down
ACON
Aclarion
2.9836 of 5 stars
$7.30
-0.3%
$11,758.50
+160,975.3%
-99.7%$4.23M$50K0.007
OTRK
Ontrak
3.1368 of 5 stars
$0.58
-9.9%
$24.00
+4,073.9%
-85.2%$2.42M$10.85M-0.04250Positive News
BACK
IMAC
N/A$0.06
+0.8%
N/A-96.7%$126K$72.05K0.00180Gap Down
ATIP
ATI Physical Therapy
N/A$0.01
-99.0%
N/A-94.2%$44K$741.86M0.005,600
BTTX
Better Therapeutics
N/AN/AN/A-66.7%$5KN/A0.0040

Related Companies and Tools


This page (NASDAQ:NIVF) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners